Rank | Gene Set | Z-score |
---|---|---|
1 | low-density lipoprotein particle clearance (GO:0034383) | 9.08384485 |
2 | regulation of sequestering of triglyceride (GO:0010889) | 8.45952442 |
3 | triglyceride catabolic process (GO:0019433) | 7.79151627 |
4 | fatty acid homeostasis (GO:0055089) | 7.03308306 |
5 | acylglycerol catabolic process (GO:0046464) | 6.94079998 |
6 | neutral lipid catabolic process (GO:0046461) | 6.94079998 |
7 | NADH metabolic process (GO:0006734) | 6.33939845 |
8 | fatty acid transmembrane transport (GO:1902001) | 5.29752082 |
9 | diacylglycerol metabolic process (GO:0046339) | 5.28255720 |
10 | glycerolipid catabolic process (GO:0046503) | 5.07105933 |
11 | brown fat cell differentiation (GO:0050873) | 5.06993516 |
12 | cellular response to epinephrine stimulus (GO:0071872) | 5.06645668 |
13 | carnitine shuttle (GO:0006853) | 4.91147320 |
14 | lipid particle organization (GO:0034389) | 4.90556010 |
15 | triglyceride biosynthetic process (GO:0019432) | 4.83747264 |
16 | biotin metabolic process (GO:0006768) | 4.73069709 |
17 | neutral lipid biosynthetic process (GO:0046460) | 4.62424879 |
18 | acylglycerol biosynthetic process (GO:0046463) | 4.62424879 |
19 | lipid storage (GO:0019915) | 4.59945432 |
20 | regulation of cholesterol storage (GO:0010885) | 4.54436010 |
21 | positive regulation of lipid storage (GO:0010884) | 4.53998590 |
22 | response to epinephrine (GO:0071871) | 4.43987105 |
23 | ethanol oxidation (GO:0006069) | 4.39066745 |
24 | oxaloacetate metabolic process (GO:0006107) | 4.26278832 |
25 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.19701295 |
26 | white fat cell differentiation (GO:0050872) | 4.18532195 |
27 | plasma lipoprotein particle clearance (GO:0034381) | 4.17061040 |
28 | cardiac myofibril assembly (GO:0055003) | 4.11796316 |
29 | acyl-CoA biosynthetic process (GO:0071616) | 4.10207355 |
30 | thioester biosynthetic process (GO:0035384) | 4.10207355 |
31 | detection of calcium ion (GO:0005513) | 4.06520360 |
32 | regulation of glycogen (starch) synthase activity (GO:2000465) | 4.04055296 |
33 | cardiac muscle contraction (GO:0060048) | 4.01435582 |
34 | alpha-linolenic acid metabolic process (GO:0036109) | 3.99464886 |
35 | phospholipid homeostasis (GO:0055091) | 3.98143098 |
36 | triglyceride metabolic process (GO:0006641) | 3.96986139 |
37 | tricarboxylic acid metabolic process (GO:0072350) | 3.93489327 |
38 | sarcomere organization (GO:0045214) | 3.93246811 |
39 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.90005735 |
40 | protein heterotrimerization (GO:0070208) | 3.89089541 |
41 | muscle filament sliding (GO:0030049) | 3.85143413 |
42 | actin-myosin filament sliding (GO:0033275) | 3.85143413 |
43 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.84769391 |
44 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.74425176 |
45 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.73569692 |
46 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.71610743 |
47 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.70983801 |
48 | acylglycerol metabolic process (GO:0006639) | 3.69533630 |
49 | myofibril assembly (GO:0030239) | 3.68383988 |
50 | acetyl-CoA metabolic process (GO:0006084) | 3.66747672 |
51 | neutral lipid metabolic process (GO:0006638) | 3.64125449 |
52 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.62850442 |
53 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.60486093 |
54 | polyol transport (GO:0015791) | 3.59795082 |
55 | potassium ion export (GO:0071435) | 3.58596700 |
56 | transcytosis (GO:0045056) | 3.58181942 |
57 | carnitine transmembrane transport (GO:1902603) | 3.57962312 |
58 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.56473573 |
59 | thioester metabolic process (GO:0035383) | 3.51410129 |
60 | acyl-CoA metabolic process (GO:0006637) | 3.51410129 |
61 | response to dietary excess (GO:0002021) | 3.46147742 |
62 | negative regulation of granulocyte differentiation (GO:0030853) | 3.41839694 |
63 | positive regulation of glomerulus development (GO:0090193) | 3.41642071 |
64 | cGMP-mediated signaling (GO:0019934) | 3.41425371 |
65 | ethanol metabolic process (GO:0006067) | 3.37221701 |
66 | phosphatidic acid biosynthetic process (GO:0006654) | 3.36892968 |
67 | phosphatidic acid metabolic process (GO:0046473) | 3.36892968 |
68 | positive regulation of cholesterol efflux (GO:0010875) | 3.36843440 |
69 | fatty acid beta-oxidation (GO:0006635) | 3.32625256 |
70 | regulation of cell communication by electrical coupling (GO:0010649) | 3.32447307 |
71 | creatine metabolic process (GO:0006600) | 3.29837561 |
72 | regulation of actin filament-based movement (GO:1903115) | 3.29439826 |
73 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.28710975 |
74 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.25858706 |
75 | primary alcohol metabolic process (GO:0034308) | 3.25819191 |
76 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.25544530 |
77 | regulation of fatty acid oxidation (GO:0046320) | 3.25403204 |
78 | carnitine transport (GO:0015879) | 3.24800677 |
79 | amino-acid betaine transport (GO:0015838) | 3.24800677 |
80 | regulation of lipid storage (GO:0010883) | 3.23704549 |
81 | actin-mediated cell contraction (GO:0070252) | 3.20120512 |
82 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.19619703 |
83 | regulation of lipoprotein metabolic process (GO:0050746) | 3.18780978 |
84 | glycerol metabolic process (GO:0006071) | 3.17276845 |
85 | regulation of the force of heart contraction (GO:0002026) | 3.17164854 |
86 | cardiac muscle hypertrophy (GO:0003300) | 3.15235034 |
87 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.13724135 |
88 | heart process (GO:0003015) | 3.12710933 |
89 | heart contraction (GO:0060047) | 3.12710933 |
90 | activation of protein kinase A activity (GO:0034199) | 3.12668933 |
91 | striated muscle hypertrophy (GO:0014897) | 3.08961919 |
92 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.08878741 |
93 | response to phenylpropanoid (GO:0080184) | 3.08453154 |
94 | long-chain fatty acid transport (GO:0015909) | 3.08010424 |
95 | cellular response to monoamine stimulus (GO:0071868) | 3.07738441 |
96 | cellular response to catecholamine stimulus (GO:0071870) | 3.07738441 |
97 | valine metabolic process (GO:0006573) | 3.07711038 |
98 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.07377731 |
99 | negative regulation of macrophage differentiation (GO:0045650) | 3.03548177 |
100 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.02846136 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.28034229 |
2 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.63976129 |
3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.28797256 |
4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.27880010 |
5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.10241641 |
6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.88604059 |
7 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.64600786 |
8 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.64600786 |
9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54602899 |
10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.39307564 |
11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.30276576 |
12 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.29097160 |
13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.18359976 |
14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 10.9177092 |
15 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.99379852 |
16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94701953 |
17 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.81449338 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76844670 |
19 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.68224199 |
20 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.67137321 |
21 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.65607074 |
22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.64528643 |
23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59601755 |
24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.57798430 |
25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54371650 |
26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54102080 |
27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.50848881 |
28 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.46331644 |
29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44127307 |
30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42708663 |
31 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.37403116 |
32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.33036047 |
33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.33036047 |
34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.32690774 |
35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29940152 |
36 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27864987 |
37 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.26914447 |
38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25761865 |
39 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22944402 |
40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21578853 |
41 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.21413814 |
42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20657975 |
43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.19049714 |
44 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.18545871 |
45 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.18362663 |
46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13928048 |
47 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12594475 |
48 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.11575401 |
49 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11529611 |
50 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10866680 |
51 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07963617 |
52 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.06291158 |
53 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.05706179 |
54 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05626276 |
55 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.04829613 |
56 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04732084 |
57 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.03162317 |
58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01662072 |
59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00966340 |
60 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97830547 |
61 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.96812632 |
62 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.90513385 |
63 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.89314812 |
64 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87414828 |
65 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87289020 |
66 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87070560 |
67 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.86854861 |
68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86365683 |
69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85503811 |
70 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85256136 |
71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84857981 |
72 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.84033673 |
73 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.83744370 |
74 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.83646009 |
75 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.82838709 |
76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81818462 |
77 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80718327 |
78 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.80646806 |
79 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.79621624 |
80 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.79026946 |
81 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.78649358 |
82 | KDM2B_26808549_Chip-Seq_K562_Human | 0.78048468 |
83 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.77917898 |
84 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.75142248 |
85 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.74790939 |
86 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.73731735 |
87 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.72366182 |
88 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.71377589 |
89 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.71257979 |
90 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.70382004 |
91 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.69735505 |
92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69530848 |
93 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.68948637 |
94 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.68813375 |
95 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68504735 |
96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.68121398 |
97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67504142 |
98 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.66919526 |
99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65616150 |
100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.65596483 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005670_abnormal_white_adipose | 7.31030270 |
2 | MP0005666_abnormal_adipose_tissue | 4.91151166 |
3 | MP0004130_abnormal_muscle_cell | 4.73363296 |
4 | MP0002971_abnormal_brown_adipose | 3.78951490 |
5 | MP0004084_abnormal_cardiac_muscle | 3.71452500 |
6 | MP0000751_myopathy | 3.71352393 |
7 | MP0005375_adipose_tissue_phenotype | 3.47369058 |
8 | MP0004185_abnormal_adipocyte_glucose | 3.40144351 |
9 | MP0006138_congestive_heart_failure | 3.05172651 |
10 | MP0004215_abnormal_myocardial_fiber | 2.95167972 |
11 | MP0002837_dystrophic_cardiac_calcinosis | 2.91567147 |
12 | MP0004036_abnormal_muscle_relaxation | 2.58218915 |
13 | MP0009115_abnormal_fat_cell | 2.44085526 |
14 | MP0003828_pulmonary_edema | 2.35256032 |
15 | MP0005385_cardiovascular_system_phenoty | 2.25012452 |
16 | MP0001544_abnormal_cardiovascular_syste | 2.25012452 |
17 | MP0002972_abnormal_cardiac_muscle | 2.19673311 |
18 | MP0005330_cardiomyopathy | 2.16358554 |
19 | MP0005334_abnormal_fat_pad | 2.11346420 |
20 | MP0000749_muscle_degeneration | 2.05282872 |
21 | MP0002970_abnormal_white_adipose | 2.04712982 |
22 | MP0004087_abnormal_muscle_fiber | 2.04675640 |
23 | MP0005535_abnormal_body_temperature | 2.01818606 |
24 | MP0010329_abnormal_lipoprotein_level | 2.01038015 |
25 | MP0008775_abnormal_heart_ventricle | 2.00730288 |
26 | MP0000003_abnormal_adipose_tissue | 1.93879304 |
27 | MP0003137_abnormal_impulse_conducting | 1.88252767 |
28 | MP0003959_abnormal_lean_body | 1.82078881 |
29 | MP0005620_abnormal_muscle_contractility | 1.72148661 |
30 | MP0003646_muscle_fatigue | 1.70952564 |
31 | MP0010630_abnormal_cardiac_muscle | 1.61744439 |
32 | MP0004484_altered_response_of | 1.61109673 |
33 | MP0002118_abnormal_lipid_homeostasis | 1.59104942 |
34 | MP0000343_altered_response_to | 1.56918931 |
35 | MP0005448_abnormal_energy_balance | 1.56100990 |
36 | MP0003011_delayed_dark_adaptation | 1.55487332 |
37 | MP0006036_abnormal_mitochondrial_physio | 1.53940280 |
38 | MP0008438_abnormal_cutaneous_collagen | 1.51057122 |
39 | MP0005503_abnormal_tendon_morphology | 1.49528519 |
40 | MP0000759_abnormal_skeletal_muscle | 1.45551797 |
41 | MP0001661_extended_life_span | 1.38069259 |
42 | MP0003186_abnormal_redox_activity | 1.37353750 |
43 | MP0002876_abnormal_thyroid_physiology | 1.31793219 |
44 | MP0000013_abnormal_adipose_tissue | 1.31031443 |
45 | MP0005452_abnormal_adipose_tissue | 1.29144062 |
46 | MP0005275_abnormal_skin_tensile | 1.28347258 |
47 | MP0003724_increased_susceptibility_to | 1.25232709 |
48 | MP0003279_aneurysm | 1.21554357 |
49 | MP0002108_abnormal_muscle_morphology | 1.20674241 |
50 | MP0004510_myositis | 1.19350577 |
51 | MP0003868_abnormal_feces_composition | 1.17176422 |
52 | MP0004085_abnormal_heartbeat | 1.16365906 |
53 | MP0002078_abnormal_glucose_homeostasis | 1.14590546 |
54 | MP0002106_abnormal_muscle_physiology | 1.14246696 |
55 | MP0002269_muscular_atrophy | 1.13665555 |
56 | MP0005165_increased_susceptibility_to | 1.11785995 |
57 | MP0004272_abnormal_basement_membrane | 1.11370807 |
58 | MP0005369_muscle_phenotype | 1.11119026 |
59 | MP0010368_abnormal_lymphatic_system | 1.10118907 |
60 | MP0002638_abnormal_pupillary_reflex | 1.08876278 |
61 | MP0003690_abnormal_glial_cell | 1.07655980 |
62 | MP0002127_abnormal_cardiovascular_syste | 1.06726172 |
63 | MP0000750_abnormal_muscle_regeneration | 1.02558511 |
64 | MP0003705_abnormal_hypodermis_morpholog | 0.98773762 |
65 | MP0003950_abnormal_plasma_membrane | 0.97363354 |
66 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97061985 |
67 | MP0000747_muscle_weakness | 0.96424367 |
68 | MP0009840_abnormal_foam_cell | 0.96340807 |
69 | MP0009780_abnormal_chondrocyte_physiolo | 0.94524078 |
70 | MP0003191_abnormal_cellular_cholesterol | 0.93868988 |
71 | MP0005167_abnormal_blood-brain_barrier | 0.91256426 |
72 | MP0003948_abnormal_gas_homeostasis | 0.87908258 |
73 | MP0002295_abnormal_pulmonary_circulatio | 0.87555858 |
74 | MP0005595_abnormal_vascular_smooth | 0.85787280 |
75 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82926328 |
76 | MP0000767_abnormal_smooth_muscle | 0.81366951 |
77 | MP0001879_abnormal_lymphatic_vessel | 0.78866036 |
78 | MP0002332_abnormal_exercise_endurance | 0.76251504 |
79 | MP0005266_abnormal_metabolism | 0.74985670 |
80 | MP0000249_abnormal_blood_vessel | 0.72339517 |
81 | MP0001958_emphysema | 0.69631659 |
82 | MP0002909_abnormal_adrenal_gland | 0.69462537 |
83 | MP0000609_abnormal_liver_physiology | 0.66711871 |
84 | MP0000230_abnormal_systemic_arterial | 0.65056610 |
85 | MP0004145_abnormal_muscle_electrophysio | 0.63478783 |
86 | MP0005647_abnormal_sex_gland | 0.63023828 |
87 | MP0003953_abnormal_hormone_level | 0.61733157 |
88 | MP0000266_abnormal_heart_morphology | 0.60932982 |
89 | MP0005164_abnormal_response_to | 0.57939958 |
90 | MP0002128_abnormal_blood_circulation | 0.57702352 |
91 | MP0002933_joint_inflammation | 0.56785186 |
92 | MP0001727_abnormal_embryo_implantation | 0.54541092 |
93 | MP0001881_abnormal_mammary_gland | 0.54260845 |
94 | MP0002139_abnormal_hepatobiliary_system | 0.53653704 |
95 | MP0005332_abnormal_amino_acid | 0.53305275 |
96 | MP0005388_respiratory_system_phenotype | 0.52443843 |
97 | MP0002133_abnormal_respiratory_system | 0.52443843 |
98 | MP0005379_endocrine/exocrine_gland_phen | 0.46544108 |
99 | MP0009672_abnormal_birth_weight | 0.42179428 |
100 | MP0005365_abnormal_bile_salt | 0.42125535 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 6.27100691 |
2 | Oligomenorrhea (HP:0000876) | 5.42613145 |
3 | Lipoatrophy (HP:0100578) | 5.30562493 |
4 | Hyporeflexia of lower limbs (HP:0002600) | 5.21885017 |
5 | Increased variability in muscle fiber diameter (HP:0003557) | 4.88164195 |
6 | Bundle branch block (HP:0011710) | 4.85027804 |
7 | Hypertriglyceridemia (HP:0002155) | 4.79408522 |
8 | Muscle fiber splitting (HP:0003555) | 4.74250825 |
9 | Atrial fibrillation (HP:0005110) | 4.71785036 |
10 | Ventricular tachycardia (HP:0004756) | 4.63193940 |
11 | Acanthosis nigricans (HP:0000956) | 4.59783815 |
12 | Difficulty running (HP:0009046) | 4.45384763 |
13 | Asymmetric septal hypertrophy (HP:0001670) | 4.33787553 |
14 | Primary atrial arrhythmia (HP:0001692) | 4.28804648 |
15 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.26397194 |
16 | Dilated cardiomyopathy (HP:0001644) | 4.15722301 |
17 | Supraventricular tachycardia (HP:0004755) | 4.14898694 |
18 | Supraventricular arrhythmia (HP:0005115) | 4.10807020 |
19 | Myoglobinuria (HP:0002913) | 3.93128166 |
20 | Rhabdomyolysis (HP:0003201) | 3.91899466 |
21 | Syncope (HP:0001279) | 3.68797119 |
22 | Atrioventricular block (HP:0001678) | 3.63382771 |
23 | Heart block (HP:0012722) | 3.57101305 |
24 | Neck muscle weakness (HP:0000467) | 3.56260741 |
25 | Abnormality of the calf musculature (HP:0001430) | 3.55029510 |
26 | Right ventricular cardiomyopathy (HP:0011663) | 3.50989656 |
27 | Distal lower limb muscle weakness (HP:0009053) | 3.50146517 |
28 | Exercise-induced myalgia (HP:0003738) | 3.48930635 |
29 | Abnormal atrioventricular conduction (HP:0005150) | 3.48800071 |
30 | Increased serum pyruvate (HP:0003542) | 3.48438532 |
31 | EMG: myopathic abnormalities (HP:0003458) | 3.37331496 |
32 | Increased connective tissue (HP:0009025) | 3.35012811 |
33 | Increased muscle lipid content (HP:0009058) | 3.22654184 |
34 | Hyperlipoproteinemia (HP:0010980) | 3.20021876 |
35 | Nausea (HP:0002018) | 3.17670482 |
36 | Ventricular arrhythmia (HP:0004308) | 3.14670774 |
37 | Skin nodule (HP:0200036) | 3.13496276 |
38 | Abnormality of glycolysis (HP:0004366) | 3.11683743 |
39 | Type 1 muscle fiber predominance (HP:0003803) | 3.06117827 |
40 | Subaortic stenosis (HP:0001682) | 3.05266410 |
41 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.05266410 |
42 | Protrusio acetabuli (HP:0003179) | 2.99000452 |
43 | Insulin resistance (HP:0000855) | 2.98497770 |
44 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.94457779 |
45 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.86219009 |
46 | Prolonged QT interval (HP:0001657) | 2.80691958 |
47 | Ragged-red muscle fibers (HP:0003200) | 2.78618362 |
48 | Abnormality of the foot musculature (HP:0001436) | 2.74501981 |
49 | Rimmed vacuoles (HP:0003805) | 2.73641824 |
50 | EMG: neuropathic changes (HP:0003445) | 2.66713714 |
51 | Myocardial infarction (HP:0001658) | 2.64209368 |
52 | Palpitations (HP:0001962) | 2.64131416 |
53 | Calf muscle hypertrophy (HP:0008981) | 2.63733356 |
54 | Complement deficiency (HP:0004431) | 2.57288161 |
55 | Frequent falls (HP:0002359) | 2.54522767 |
56 | Foot dorsiflexor weakness (HP:0009027) | 2.54209843 |
57 | Scapular winging (HP:0003691) | 2.53674066 |
58 | Epidermoid cyst (HP:0200040) | 2.49827946 |
59 | Hypercortisolism (HP:0001578) | 2.44895777 |
60 | Growth hormone excess (HP:0000845) | 2.43020668 |
61 | Spinal rigidity (HP:0003306) | 2.42608424 |
62 | Hypoglycemic coma (HP:0001325) | 2.41164221 |
63 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.40560356 |
64 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.40366082 |
65 | Axonal loss (HP:0003447) | 2.38864739 |
66 | Ventricular fibrillation (HP:0001663) | 2.33260050 |
67 | Abnormal EKG (HP:0003115) | 2.31347443 |
68 | Hemorrhage of the eye (HP:0011885) | 2.28782023 |
69 | Bone cyst (HP:0012062) | 2.25519932 |
70 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.24809821 |
71 | Gowers sign (HP:0003391) | 2.24332867 |
72 | Xanthomatosis (HP:0000991) | 2.24321827 |
73 | Long foot (HP:0001833) | 2.19833510 |
74 | Lymphangioma (HP:0100764) | 2.19571384 |
75 | Pigmentary retinal degeneration (HP:0001146) | 2.16978497 |
76 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.16936233 |
77 | Infantile muscular hypotonia (HP:0008947) | 2.16591152 |
78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15558491 |
79 | Dicarboxylic aciduria (HP:0003215) | 2.15558491 |
80 | Hypercholesterolemia (HP:0003124) | 2.13440477 |
81 | Back pain (HP:0003418) | 2.12390928 |
82 | Aortic aneurysm (HP:0004942) | 2.12257728 |
83 | Bradycardia (HP:0001662) | 2.11361510 |
84 | Polycythemia (HP:0001901) | 2.07216647 |
85 | Abnormality of complement system (HP:0005339) | 2.03992421 |
86 | Resting tremor (HP:0002322) | 2.03647545 |
87 | Abnormality of alanine metabolism (HP:0010916) | 2.03315486 |
88 | Hyperalaninemia (HP:0003348) | 2.03315486 |
89 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.03315486 |
90 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.00250770 |
91 | Pulmonary artery stenosis (HP:0004415) | 1.99864105 |
92 | Prominent supraorbital ridges (HP:0000336) | 1.98674807 |
93 | Bulbar palsy (HP:0001283) | 1.98532030 |
94 | Generalized muscle weakness (HP:0003324) | 1.95847174 |
95 | Vertebral compression fractures (HP:0002953) | 1.94149967 |
96 | Distal lower limb amyotrophy (HP:0008944) | 1.92038137 |
97 | Sudden cardiac death (HP:0001645) | 1.90178474 |
98 | Areflexia of lower limbs (HP:0002522) | 1.87105633 |
99 | Steppage gait (HP:0003376) | 1.84473884 |
100 | Myotonia (HP:0002486) | 1.82922662 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MYLK | 5.95539213 |
2 | TTN | 4.37153613 |
3 | TRIB3 | 3.37252688 |
4 | PRKAA2 | 2.63962847 |
5 | TIE1 | 2.54711526 |
6 | EPHB2 | 2.53347267 |
7 | RIPK1 | 2.37416637 |
8 | TGFBR2 | 2.24566984 |
9 | CAMK1 | 2.23791735 |
10 | OBSCN | 2.23195524 |
11 | SIK1 | 2.21374856 |
12 | PINK1 | 2.17600580 |
13 | DMPK | 2.12264171 |
14 | MAP3K6 | 1.92651564 |
15 | DDR2 | 1.86409603 |
16 | NEK9 | 1.76159020 |
17 | MAPK12 | 1.70316304 |
18 | LATS2 | 1.69093260 |
19 | CAMK1D | 1.57541992 |
20 | TESK1 | 1.56239131 |
21 | MAPK4 | 1.53424890 |
22 | PRKAA1 | 1.50561075 |
23 | MAPKAPK3 | 1.45725540 |
24 | CDC42BPA | 1.42443150 |
25 | PDK2 | 1.40747376 |
26 | PKN2 | 1.40384146 |
27 | PRKD1 | 1.30010066 |
28 | TRPM7 | 1.25573415 |
29 | MUSK | 1.24904156 |
30 | DAPK3 | 1.22700701 |
31 | PAK3 | 1.21323372 |
32 | ERN1 | 1.21077457 |
33 | MAP2K1 | 1.13665867 |
34 | ABL2 | 1.11955332 |
35 | EEF2K | 1.00880787 |
36 | PDPK1 | 1.00840916 |
37 | PDGFRA | 0.99916714 |
38 | EPHA3 | 0.99130867 |
39 | ARAF | 0.97261420 |
40 | PRKACG | 0.97042426 |
41 | PIK3CA | 0.96860101 |
42 | CDK6 | 0.95918236 |
43 | LATS1 | 0.95067668 |
44 | PHKG2 | 0.93886580 |
45 | PHKG1 | 0.93886580 |
46 | MAP3K5 | 0.91920452 |
47 | CAMK1G | 0.91183386 |
48 | ROCK1 | 0.88307105 |
49 | GRK5 | 0.85350544 |
50 | EPHB1 | 0.80835470 |
51 | BCKDK | 0.80549770 |
52 | CAMK2D | 0.78016542 |
53 | LMTK2 | 0.74966064 |
54 | STK4 | 0.74728282 |
55 | MAP3K7 | 0.74107815 |
56 | PRPF4B | 0.71527920 |
57 | STK38L | 0.71347798 |
58 | NLK | 0.69943013 |
59 | ILK | 0.68504893 |
60 | GSK3A | 0.66765634 |
61 | PRKG1 | 0.64514203 |
62 | PKN1 | 0.63889362 |
63 | CAMK4 | 0.62151251 |
64 | RPS6KC1 | 0.61385124 |
65 | RPS6KL1 | 0.61385124 |
66 | MAP2K3 | 0.61354513 |
67 | MAPK7 | 0.60957421 |
68 | PRKCE | 0.58619493 |
69 | CAMKK2 | 0.55711130 |
70 | PAK2 | 0.54679342 |
71 | PDK1 | 0.54281992 |
72 | ADRBK1 | 0.54220604 |
73 | MOS | 0.53402069 |
74 | MARK1 | 0.53304515 |
75 | ROCK2 | 0.52380348 |
76 | MTOR | 0.51383032 |
77 | RPS6KA6 | 0.50013481 |
78 | CDK4 | 0.49888099 |
79 | RET | 0.49003084 |
80 | PRKACA | 0.47736673 |
81 | AKT2 | 0.46175669 |
82 | CAMK2G | 0.45987238 |
83 | PRKACB | 0.45899874 |
84 | JAK2 | 0.45733787 |
85 | ICK | 0.44683562 |
86 | IGF1R | 0.44284272 |
87 | KSR2 | 0.44140620 |
88 | RPS6KA3 | 0.43884779 |
89 | CAMK2A | 0.43475041 |
90 | GRK7 | 0.43429618 |
91 | PIM2 | 0.42932629 |
92 | MAPK3 | 0.42350614 |
93 | PDGFRB | 0.41998364 |
94 | TBK1 | 0.41729683 |
95 | CSK | 0.39731236 |
96 | STK38 | 0.39350822 |
97 | MAP3K13 | 0.37104326 |
98 | ZAP70 | 0.34813401 |
99 | KDR | 0.33541459 |
100 | CDK9 | 0.33273317 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.42241867 |
2 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.10296566 |
3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.75737232 |
4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.56477962 |
5 | Pyruvate metabolism_Homo sapiens_hsa00620 | 3.19039232 |
6 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.13884955 |
7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.08326311 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.03165983 |
9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.99391183 |
10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.98752449 |
11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.94534219 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.83470739 |
13 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.75205479 |
14 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.38708750 |
15 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.00908352 |
16 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.97634555 |
17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.94021788 |
18 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.82536563 |
19 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.74812124 |
20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.66846955 |
21 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.62520095 |
22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.60397174 |
23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.54475871 |
24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.54190392 |
25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40511623 |
26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35666832 |
27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19192707 |
28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.16063728 |
29 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.15216869 |
30 | Renin secretion_Homo sapiens_hsa04924 | 1.12631833 |
31 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.09445366 |
32 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.04135974 |
33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.97911798 |
34 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.95082571 |
35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.91005338 |
36 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.89033111 |
37 | Insulin resistance_Homo sapiens_hsa04931 | 0.85470668 |
38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85345663 |
39 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84044641 |
40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.81800792 |
41 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.81685144 |
42 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.79369654 |
43 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76993719 |
44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75684218 |
45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74047165 |
46 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70658487 |
47 | Peroxisome_Homo sapiens_hsa04146 | 0.70255124 |
48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69985640 |
49 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64171622 |
50 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63220162 |
51 | Focal adhesion_Homo sapiens_hsa04510 | 0.61592159 |
52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58241411 |
53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57129388 |
54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50717120 |
55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48402581 |
56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47593057 |
57 | Lysine degradation_Homo sapiens_hsa00310 | 0.46908049 |
58 | Parkinsons disease_Homo sapiens_hsa05012 | 0.45766298 |
59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45094013 |
60 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38991496 |
61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36625766 |
62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34669111 |
63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34062914 |
64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32283185 |
65 | Malaria_Homo sapiens_hsa05144 | 0.31943842 |
66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31587970 |
67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31137245 |
68 | Bile secretion_Homo sapiens_hsa04976 | 0.30674412 |
69 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.29261672 |
70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28595089 |
71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.27503120 |
72 | Morphine addiction_Homo sapiens_hsa05032 | 0.26432321 |
73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.25415529 |
74 | Cocaine addiction_Homo sapiens_hsa05030 | 0.20602536 |
75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.19035741 |
76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.18133712 |
77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.17330751 |
78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16107542 |
79 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.15917915 |
80 | Melanogenesis_Homo sapiens_hsa04916 | 0.15487944 |
81 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.14135887 |
82 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.14021561 |
83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13825834 |
84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.13302295 |
85 | Tight junction_Homo sapiens_hsa04530 | 0.12955727 |
86 | Gap junction_Homo sapiens_hsa04540 | 0.12718429 |
87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.12625406 |
88 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.09229007 |
89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.09107006 |
90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.08839168 |
91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.07959949 |
92 | ABC transporters_Homo sapiens_hsa02010 | 0.07906048 |
93 | Circadian entrainment_Homo sapiens_hsa04713 | 0.07693908 |
94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.07289812 |
95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.06884111 |
96 | Amoebiasis_Homo sapiens_hsa05146 | 0.05908407 |
97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.05643173 |
98 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.05616042 |
99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.05199368 |
100 | Platelet activation_Homo sapiens_hsa04611 | 0.04132457 |